Quadrise PLC (QED) · 2026-11-16
Valkor funds receipt
Quadrise PLC has received US$300,000 of the Utah site licence fee, but deployment remains dependent on Valkor paying the remaining US$650,000 after its fundraising completes.
UK company announcements filtered and explained for private investors.
Quadrise PLC (QED) · 2026-11-16
Quadrise PLC has received US$300,000 of the Utah site licence fee, but deployment remains dependent on Valkor paying the remaining US$650,000 after its fundraising completes.
Applied Nutrition PLC (APN) · 2026-11-16
In unaudited preliminary FY26 results, Applied Nutrition PLC delivered adjusted EBITDA of £43.3m, up 40.1% and in line with management guidance upgraded in August 2026, while the Board maintained FY27 expectations of approximately £205m revenue and £49m adjusted EBITDA but expects EBITDA margin to decrease slightly from FY26 levels. Free cash flow after tax fell to £10.6m from £16.5m, while working-capital usage increased, and no dividend is expected before FY28.
Solid State PLC (SOLI) · 2026-11-16
Solid State expects H1 revenue above £87.5m and adjusted PBT above £5.0m, ahead of the prior year despite lower NSPA revenue, and remains confident of meeting FY2026/27 market expectations, but significant second-half working-capital investment and capex may increase full-year net debt.
SIRIUS REAL ESTATE LD (SRE) · 2026-11-16
Sirius Real Estate said first-half trading was in line with management expectations and it remains on track towards its medium-term ambition of €175m annual FFO, after FFO rose to €72.4m and FFO per share increased 6.5% to 4.58c. The interim dividend rose 5.3%, but reported pre-tax profit fell 37.4% on a revaluation deficit and net LTV increased to 39.0%, within its 40.0% cap.
Grafton Group PLC (GFTU) · 2026-11-16
Grafton said trading was in line with expectations and maintained full-year 2026 adjusted operating profit guidance of £190m–£200m, as Group average daily like-for-like revenue in constant currency improved to 2.0% in the 1 July to 31 October period from 0.6% in the first half, while Great Britain average daily like-for-like revenue in constant currency declined 5.2% over the same period. Revenue for the financial year to 31 October 2026 rose 7.4% to £2.29bn, supported by acquisitions.
Legal & General Group PLC (LGEN) · 2026-11-16
Legal & General expects 2026 core operating EPS growth above the top end of its 6%-9% target range, although Asset Management recorded £28bn of year-to-date net outflows versus £8bn a year earlier. Retirement, retail annuities, workplace and protection businesses showed continued momentum, while the Solvency II coverage ratio reached 213% at 30 September.
Bunzl PLC has started a second share-buyback tranche of up to £250 million, supporting its plan to reduce issued share capital. It may buy up to 23,045,802 shares by 22 December 2026.
IG Group Holdings PLC (IGG) · 2026-11-16
IG Group Holdings has established a new Jersey holding company under its effective scheme, with former shares suspended ahead of an expected replacement listing.
Empire Metals Ltd (EEE) · 2026-11-16
Empire Metals Ltd has paused AIM trading while it finalises a prospectus for a proposed A$8 million ASX CDI offer, so the funding is not yet complete. The offer is expected to issue 14,285,715 CDIs at A$0.56 each, equivalent to 28.7p per share at a GBP/AUD rate of 1.95.
Kelso Group Holdings PLC (KLSO) · 2026-11-16
Kelso Group Holdings' estimated unaudited NAV per share was 3.9p at 13 November 2026, up 68% since 1 January 2026. Net assets rose from £10.3m to £21.6m, reflecting estimated portfolio gains of about £9.2m and £3.4m of new funds raised, net of costs, financing charges, taxes and share buybacks.
Triad Group PLC (TRD) · 2026-11-16
Triad Group PLC increased first-half revenue and profit before tax, but operating cash inflow fell to £0.764m from £1.137m and post-tax profit fell to £0.738m. Cash was £3.779m at 30 September 2026, down from £4.175m at 31 March after dividends, lease payments and capital expenditure.
Hercules PLC (HERC) · 2026-11-16
Hercules PLC’s Advantage NRG renewed its 2027 framework with United Infrastructure and secured an initial £1.8m overhead-line contract in Bristol. The framework has no fixed value, and further 2027 revenue depends on separately awarded work packages.
Synectics PLC (SNX) · 2026-11-16
Synectics PLC has won a £2.0 million defence contract award and maintenance extension, adding expected H1 FY27 project revenue and recurring income through March 2030.
Frasers Group PLC (FRAS) · 2026-11-16
Frasers Group PLC disclosed that MASH Holdings, linked to PDMR Michael Ashley, sold 144,000 shares for £1,365,840 under a previously announced trading programme.
Pathos Communications PLC (NEWS) · 2026-11-16
Pathos Communications is buying 100% of Entrepreneurs on Fire for US$3.0 million upfront cash plus up to US$6.0 million of performance-linked deferred consideration, with completion expected around 18 November 2026. It expects the deal to enhance adjusted earnings, before acquired-intangibles amortisation, and free cash flow in the first full year after completion, before synergies.
Westmount Energy Ltd (WTE) · 2026-11-16
Westmount Energy returned to total comprehensive income of £263,542 for the year ended 30 June 2026, from a £551,794 loss, but cash fell to £110,274 and meeting obligations depends on timely sales of quoted investments, subject to market conditions. Directors said cash alone could not cover year-end payables.
Nativo Resources PLC (NTVO) · 2026-11-16
Nativo Resources will issue 205,000,000 new ATM shares to Axis, expanding the share base by about 10.82% on an enlarged basis and potentially diluting existing holders. Its Tesoro sampling programme is scheduled to begin this week to refine a shaft location, but any mining restart depends on its findings, mine design, ground conditions and available funding.
Litigation Capital Management Ltd (LIT) · 2026-11-16
Litigation Capital Management has extended Northleaf’s debt covenant waiver from 13 November to 27 November 2026, but its loan interest remains 2.00% a year higher during the extension. The short extension keeps covenant pressure in place, although no further one-off waiver fee applies.
Me Group International PLC (MEGP) · 2026-11-16
ME Group expects FY 2026 revenue of at least c.£309m and adjusted profit before tax of at least c.£66m, while Wash.ME revenue is expected to rise c.14% but Photo.ME revenue is expected to fall c.4%. Wash.ME added 1,224 net machines, lifting its estate c.16% year on year, despite weaker drying demand in hot, dry European weather.
Sealand Capital Galaxy Ltd (SCGL) · 2026-11-16
Sealand Capital Galaxy Ltd received £88,589.34 in gross proceeds from Conversion A warrant exercises, but a large outstanding warrant pool could lead to further share issuance.
CML Microsystems PLC (CML) · 2026-11-16
CML Microsystems PLC has appointed Adrian Spencer Keane to its Board as Chief Financial Officer from 1 February 2027, adding an executive with more than 30 years of financial and commercial experience. The disclosure also records that companies where he was a director entered administration in 2012, with insufficient funds for unsecured creditors.
WH Smith PLC (SMWH) · 2026-11-16
WH Smith PLC Executive Committee member Huw Crwys-Williams bought 17,837 shares, adding a positive management ownership signal.
AstraZeneca PLC (AZN) · 2026-11-16
AstraZeneca has won EU approval for Klygefa as an add-on treatment for specified adults with generalised myasthenia gravis, extending its authorised use into a major market.
Ceres Power Holdings PLC (CWR) · 2026-11-16
Ceres Power has signed a non-exclusive EMEA manufacturing licence for its Endura fuel-cell technology with an unnamed European energy-technology company, and expects FY26 revenue of approximately £60 million after recognising contract-related revenue this year. The deal brings upfront licence fees, with recurring royalties only once commercial production begins.
Hutchmed (China) Ltd (HCM) · 2026-11-16
Hutchmed (China) Ltd secured expanded Chinese reimbursement coverage for ELUNATE and ORPATHYS from 1 January 2027, while existing coverage continues for its three listed products. The commercial effect on sales and pricing remains uncertain.
MHA PLC intends to rebrand as Baker Tilly in the UK from 1 February 2027, subject to completion of Baker Tilly International’s acquisition of the UK naming rights and licensing arrangements. The company says its strategy, client services and network membership will not change.
H-POWER PLC (HPOW) · 2026-11-16
H-Power has launched its 100kW LC100dc fuel-cell generator at a major UK construction project under a revenue-generating contract. The unit delivers more than three times the LC30’s power output at less than half its per-kW cost.
Victrex PLC (VCT) · 2026-11-16
Victrex PLC has appointed Adam Butcher as CFO and Executive Director from 15 February 2027, completing its executive leadership refresh. Chris Gilbert will remain Interim CFO until then and support the handover.
AstraZeneca PLC (AZN) · 2026-11-16
AstraZeneca PLC has won FDA approval for Klygefa for adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis, supported by a statistically significant Phase III improvement in daily-living scores versus placebo at week 26.
SThree PLC (STEM) · 2026-11-16
SThree PLC remains in an offer period and bought 16,733 shares under its buyback programme on 13 November 2026, intending to cancel them.
COPPA COLLECTIVE PLC (COPC) · 2026-11-16
Coppa Collective has signed a long-term lease for its first London location combining all-day dining, drinks and social spaces with boutique accommodation, at Greenwich Peninsula. It expects to invest about £3 million, net of landlord contribution, within planned capex and funded through its existing HSBC facility; the site is expected to open in summer 2027, subject to fit-out and outstanding licensing.
THALIA THERAPEUTICS PLC (THAT) · 2026-11-16
Thalia Therapeutics reported preliminary Phase I signs of biological and clinical activity for miRisten in relapsed or refractory AML, but results cover only nine heavily pretreated patients and topline data are targeted for H1 2027. Eight patients had no dose-limiting toxicity, although one patient had differentiation syndrome alongside an infection and was taken off treatment.
Critical Mineral Resources PLC (CMRS) · 2026-11-16
Critical Mineral Resources PLC’s 15 new drillholes at Agadir Melloul returned shallow copper-silver intercepts, led by 2.2m at 2.5% copper and 77g/t silver from 18.35m, while tighter infill spacing is intended to improve inputs for a maiden Mineral Resource Estimate. The work remains exploration-stage, with drilling and assays continuing and density, metallurgical and recovery work still planned.
Georgina Energy PLC (GEX) · 2026-11-16
Georgina Energy has ordered all long-lead equipment for the Hussar EP513 well and completed site preparation, but weather-related road restrictions must be addressed before safe rig mobilisation and no revised spud date was provided.
Abingdon Health PLC (ABDX) · 2026-11-16
Abingdon Health signed an exploratory MedTech collaboration MoU with CPI, creating a potential route from early technology development to validation, regulatory support, scalable manufacturing and commercial deployment.
Rome Resources PLC (RMR) · 2026-11-16
Rome Resources has started pilot tin mining at Kalayi, producing about 2,000kg of concentrate for intended local sale since June 2026, but commercial-scale production remains conditional on a full Mining Licence.
Kavango Resources PLC (KAV) · 2026-11-16
Kavango Resources completed independent regional modelling of the prospective D’Kar Formation across much of its Kalahari Copper Belt licence area, creating a framework to prioritise future drill targets. The model is interpretive and may not be confirmed by drilling, while any exploration programme remains subject to funding, licence, permitting and other risks.
Helix Exploration PLC (HEX) · 2026-11-16
Helix Exploration completed Ross #1 on schedule and within budget, with elevated helium shows in the Souris River and Red River formations. The readings are not laboratory gas analyses, and commercial production remains unproven pending well testing.
EMV Capital PLC (EMVC) · 2026-11-16
AMR Bio, in which EMV Capital holds a direct 29.7% interest, received supportive FDA feedback on the proposed Phase 3 design for XF-73 Nasal. AMR Bio must incorporate the FDA’s recommendations before it expects to submit full Phase 3 protocols in the coming months.
Rc365 Holding PLC (RCGH) · 2026-11-16
RC365 Holding has launched its virtual card capability from 16 November 2026, subject to onboarding, eligibility and service terms, adding a digital payment option alongside its physical cards. The launch follows a limited-user soft launch, but any cost savings are unquantified, depend on adoption and are not assured to be material or financially positive.
Aterian PLC (ATN) · 2026-11-16
Aterian PLC identified fault-controlled copper-silver mineralisation over about 350 m of strike at Amzwaro South, but several other geophysical anomalies appear linked to weathered rocks or weak secondary copper mineralisation. Initial results came from a 480 m, 17-trench programme funded through its AI joint venture with Lithosquare.
Acuity RM Group PLC (ACRM) · 2026-11-16
Acuity RM Group has won a further contract for a second on-premises STREAM deployment with the programme’s second prime defence contractor, adding recurring revenue of more than £80,000 a year. The contract excludes set-up, implementation and configuration services.
Dar Global PLC (DAR) · 2026-11-16
Dar Global PLC has acquired land for about US$56m for a planned Jeddah mixed-use development with estimated gross development value of about SAR1bn (US$267m). The project forms part of its expected Saudi portfolio expansion of up to SAR4bn.
Great Portland Estates plc (GPE) · 2026-11-16
Great Portland Estates completed the sale of 2 Aldermanbury Square to Rothesay Life for a £422.3 million headline price, with a £368.7 million net price after outstanding rent-free adjustments. The net price was around 3% ahead of the March 2026 book value and in line with the September 2026 book value.
Cleantech Lithium PLC (CTL) · 2026-11-16
Cleantech Lithium’s Laguna Verde CEOL ratification has slipped beyond the government’s previously indicated timetable, delaying a contract milestone needed to progress development. CTL says it received no official communication but understands the decree was returned with observations, not rejected, and that the Ministry is addressing them.
Staffline Group PLC (STAF) · 2026-11-16
Staffline Group PLC reported matched sale and purchase transactions by a company linked to Chairman Thomas Spain, leaving its disclosed holding unchanged at 29.98%.
Aptamer Group PLC (APTA) · 2026-11-16
Aptamer Group has refreshed its leadership around therapeutic development, appointing Dr Paloma Giangrande as a Non-Executive Director and Dr James McNamara to lead oligonucleotide therapeutics, while Dr David Bunka leaves the Board but remains Head of R&D. The CEO said the AI/ML build finished six months early, automation is integrated and the first Optimer-targeted radiotherapy in vivo study is under way.
Intercede Group PLC (IGP) · 2026-11-16
Intercede Group appointed Peter Kear as an independent Non-Executive Director and Remuneration Committee chair with immediate effect. John Linwood stepped down immediately as a Non-Executive Director and left his committee roles.
Blackbird PLC (BIRD) · 2026-11-16
Blackbird PLC said Ian McDonough has stepped down as a director and ceased to be an employee, with CEO Sumit Rai leading the company into its next phase.
Coca-Cola HBC AG (CCH) · 2026-11-16
Coca-Cola HBC AG expects to complete its acquisition of Coca-Cola Beverages Africa on 27 November 2026, subject to the JSE secondary listing becoming effective and unconditional and LSE and JSE approval for admission of GFI’s new shares. At completion, it expects to issue 21,027,676 shares to GFI, equal to 5.45% of enlarged share capital and reducing existing holders’ percentage ownership; Tanzania remains outside implementation until its Fair Competition Commission approves the deal.